Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology · Welander Distal Myopathy

Why is Welander Distal Myopathy Mistaken for sIBM?

At a Glance

Welander Distal Myopathy (WDM) is a genetic condition often misdiagnosed as sIBM because both cause hand and leg weakness and show rimmed vacuoles on biopsies. WDM affects extensor muscles and is caused by a TIA1 gene mutation, while sIBM affects flexors and involves inflammation.

It is common for patients with Welander Distal Myopathy (WDM) to be initially misdiagnosed with sporadic Inclusion Body Myositis (sIBM). If this happened to you, it is usually because both conditions appear later in life, cause weakness in the hands and legs, and look remarkably similar under a microscope [1][2]. However, WDM and sIBM are fundamentally different diseases. WDM is a hereditary genetic condition [3], while sIBM is an acquired disease that involves both inflammation and muscle degeneration [2][4].

Doctors can definitively distinguish between the two by looking closely at the specific muscles that are weak, checking for signs of inflammation in a muscle biopsy, and ultimately, performing genetic testing [5][3].

Why the Confusion Happens

The primary reason WDM is mistaken for sIBM comes down to a specific feature found in a muscle biopsy (a small sample of muscle tissue removed for testing). When doctors look at muscle tissue from a patient with WDM or sIBM under a microscope, they will often see rimmed vacuoles [2][6]. These are tiny, empty-looking bubbles or spaces inside the muscle cells where proteins have clumped together.

Because sIBM is much more common than WDM, and both tend to affect adults over the age of 50, a pathologist seeing rimmed vacuoles in an older patient’s biopsy might immediately suspect sIBM [1][7].

Key Differences in Symptoms

While both diseases cause weakness in the arms and legs, they affect different specific muscles:

  • Welander Distal Myopathy (WDM) primarily affects the extensor muscles in the hands and feet [3][1]. These are the muscles used to straighten your fingers or lift your foot upward (preventing “foot drop”).
  • Sporadic Inclusion Body Myositis (sIBM) typically affects the flexor muscles of the fingers (weakening your grip) and the muscles of the front of the thigh (the knee extensors, which causes knee buckling and falls) [3][5]. It also frequently causes difficulty swallowing (dysphagia), which is not a hallmark of WDM [8]. Additionally, sIBM often affects one side of the body more than the other (asymmetric weakness) [5].

Confirming the Diagnosis

To know for sure that you have WDM and not sIBM, your medical team will rely on a few key distinctions:

1. Lack of Inflammation on Biopsy

While both conditions show rimmed vacuoles, a biopsy from a patient with sIBM typically shows endomysial inflammation [5][6]. This means the immune system’s cells (specifically T-cells) are actively invading and attacking the muscle tissue [6]. In WDM, this aggressive inflammatory attack is generally absent [5][6].

2. Genetic Testing

The most definitive way doctors know you have WDM is through genetic testing. WDM is an inherited disorder caused by a specific mutation in the TIA1 gene [3][1]. A blood test or saliva sample that identifies this genetic mutation confirms the diagnosis of WDM [3].

In contrast, sIBM does not have a single known genetic cause and is considered a sporadic (non-inherited) disease [3]. There is no genetic test that diagnoses sIBM [9].

3. Blood Tests for sIBM

Some doctors may run a blood test looking for an autoantibody called anti-cN1A [10]. The presence of this antibody strongly points toward sIBM rather than a genetic myopathy [10].

Why Getting it Right Matters

Accurate diagnosis is critical because the management for these conditions is entirely different. Getting the correct diagnosis of WDM prevents you from undergoing unnecessary immune-suppressing treatments that are sometimes tried for inflammatory conditions like sIBM [4][11]. Since sIBM itself is notoriously resistant to standard immunosuppressants, avoiding these heavy medications is highly beneficial for your overall health [4].

Instead, a confirmed WDM diagnosis allows you to focus on the proper management strategies for your specific condition. While there is currently no cure for WDM, management focuses on supportive care, such as working with a physical therapist to maintain mobility and using orthotics (like ankle-foot braces) to manage foot drop [3][1].

Finally, a definitive WDM diagnosis provides vital information for your family. WDM is an autosomal dominant condition [3][1]. This means that if you have the mutated gene, there is a 50% chance of passing it on to each of your children [3]. Knowing this allows you to seek genetic counseling to help your family understand the risks and make informed decisions regarding their own testing and future planning [3].

Common questions in this guide

Why is Welander Distal Myopathy often misdiagnosed as sIBM?
Both WDM and sIBM affect adults over the age of 50, cause weakness in the hands and legs, and show tiny empty spaces called 'rimmed vacuoles' on a muscle biopsy. Because sIBM is much more common, doctors evaluating these symptoms may initially suspect it.
How do the symptoms of WDM and sIBM differ?
WDM primarily weakens the extensor muscles, making it hard to straighten your fingers or lift your foot. In contrast, sIBM typically weakens the flexor muscles, reducing grip strength, and often causes knee buckling and difficulty swallowing.
How is Welander Distal Myopathy diagnosed genetically?
WDM is an inherited disorder caused by a specific mutation in the TIA1 gene. A blood or saliva test that identifies this mutation can definitively confirm a WDM diagnosis.
Is there a genetic test for sIBM?
No, sporadic Inclusion Body Myositis (sIBM) does not have a single known genetic cause and is not inherited. Instead of genetic testing, doctors may look for an autoantibody called anti-cN1A in the blood to help diagnose sIBM.
What is the difference on a muscle biopsy between WDM and sIBM?
A muscle biopsy for sIBM typically shows endomysial inflammation, meaning immune cells are actively attacking the muscle tissue. In WDM, this aggressive inflammatory attack is generally absent, even though both conditions show rimmed vacuoles.
Why is getting the right diagnosis between WDM and sIBM so important?
An accurate WDM diagnosis prevents you from taking unnecessary and potentially harmful immune-suppressing medications often used for sIBM. It also allows you to focus on proper management, like physical therapy and orthotics, and provides vital information for genetic counseling.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my biopsy report specifically describe T-cell inflammation, or only rimmed vacuoles?
  2. 2.What specific genetic tests or panels will be used to look for the TIA1 mutation?
  3. 3.Now that we know this is a genetic myopathy, should I be referred to a genetic counselor to discuss the implications for my children?
  4. 4.What supportive care strategies, such as orthotics or targeted physical therapy, can help me manage the extensor weakness in my hands and feet?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Whole Exome Sequencing Identifies Atypical Welander Distal Myopathy in Patient.

    Gass J, Blackburn P, Jackson J, et al.

    Journal of clinical neuromuscular disease 2017; (18(3)):152-156 doi:10.1097/CND.0000000000000164.

    PMID: 28221306
  2. 2

    Welander Distal Myopathy-Associated TIA1 E384K Mutation Disrupts Stress Granule Dynamics Under Distinct Stress Conditions.

    Ramos-Velasco B, Alcalde J, Izquierdo JM

    Biology 2025; (14(9)) doi:10.3390/biology14091288.

    PMID: 41007432
  3. 3

    A Heterologous Cell Model for Studying the Role of T-Cell Intracellular Antigen 1 in Welander Distal Myopathy.

    Carrascoso I, Sánchez-Jiménez C, Silion E, et al.

    Molecular and cellular biology 2019; (39(1)) doi:10.1128/MCB.00299-18.

    PMID: 30348840
  4. 4

    Misdiagnosis of inclusion body myositis: two case reports and a retrospective chart review.

    Chilingaryan A, Rison RA, Beydoun SR

    Journal of medical case reports 2015; (9()):169 doi:10.1186/s13256-015-0647-z.

    PMID: 26268316
  5. 5

    Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy.

    Weihl CC, Mammen AL

    Neuropathology and applied neurobiology 2017; (43(1)):82-91 doi:10.1111/nan.12384.

    PMID: 28111778
  6. 6

    Panorama of the distal myopathies.

    Savarese M, Sarparanta J, Vihola A, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):245-265 doi:10.36185/2532-1900-028.

    PMID: 33458580
  7. 7

    Sporadic Inclusion Body Myositis and Other Rimmed Vacuolar Myopathies.

    Weihl CC

    Continuum (Minneapolis, Minn.) 2019; (25(6)):1586-1598 doi:10.1212/CON.0000000000000790.

    PMID: 31794461
  8. 8

    Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

    Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, et al.

    Orphanet journal of rare diseases 2017; (12(1)):86 doi:10.1186/s13023-017-0640-2.

    PMID: 28490364
  9. 9

    Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.

    Weihl CC, Baloh RH, Lee Y, et al.

    Neuromuscular disorders : NMD 2015; (25(4)):289-96.

    PMID: 25617006
  10. 10

    Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis.

    Paul P, Liewluck T, Ernste FC, et al.

    Muscle & nerve 2021; (63(4)):490-496 doi:10.1002/mus.27157.

    PMID: 33373040
  11. 11

    Differential Diagnoses of Inclusion Body Myositis.

    Vivekanandam V, Bugiardini E, Merve A, et al.

    Neurologic clinics 2020; (38(3)):697-710 doi:10.1016/j.ncl.2020.03.014.

    PMID: 32703477

This page explains the differences between Welander Distal Myopathy and sIBM for informational purposes only and does not constitute medical advice. Always consult your neurologist or neuromuscular specialist regarding your specific diagnosis and treatment plan.

Get notified when new evidence is published on Distal myopathy, Welander type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.